Drug shows promise for controlling Epstein-Barr Virus

Duke researchers have shown that Epstein-Barr virus (EBV) uses autophagy as a means to compensate for metabolic stress to transform primary human B cells. According to new findings that appear in Proceedings of the National Academy of Sciences, disrupting cell’s supply chain freezes the virus.
More …